Carnegie Investment Bank Norway is proud to have acted as financial advisor to Carasent ASA in relation to the acquisition of Medrave Software.
Medrave is a market leader in Scandinavia within quality improvement software and business intelligence tools for healthcare practices within primary care and secondary outpatient care. Their quality improvement solution automatically collects and sorts data, analyze and visualize, tracks and benchmarks KPIs, and provides automatic reporting.
Medrave’s complementary products will strengthen Carasent’s offering and provide cross sale potential within primary and specialist care in Sweden. Medrave is also aiming to scale up their presence in the Norwegian market, which is well in line with Carasent’s own strategy of launching Webdoc in Norway.
The transaction is expected to close during January 2022.
Carnegie congratulates Chairman Johan Lindqvist, CEO Dennis Höjer, CFO Svein Martin Bjørnstad and the rest of the Carasent team with a successful transaction.